ArticleJournal of geriatric oncology2020
Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma.
Article in Journal of geriatric oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 29 citations in OpenAlex.
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome.Cancers · 2023Article
- Mucormycosis, one month after recovery from COVID-19: A case report.Annals of medicine and surgery (2012) · 2022Article
- Review
- The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Should we screen patients with hematologic malignancies for COVID-19?Hematological oncology · 2020Review
- Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.Haematologica · 2020Article
- Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.Cancer medicine · 2020Article
- Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.Annals of hematology · 2020Observational
- Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.Blood cancer journal · 2020Article
- COVID-19: The Impact in Oncology Care.SN comprehensive clinical medicine · 2020Review
- Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic.Frontiers in oncology · 2020Article
- Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned.Frontiers in oncology · 2020Review
- Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.SN comprehensive clinical medicine · 2020Review
- Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.Frontiers in oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 9 institutions in 5 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.